⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3255643 | 0.74 | — | — | |
| SCHEMBL4711905 | 0.72 | — | — | |
| SCHEMBL30802808 | 0.72 | — | — | |
| SCHEMBL6032187 | 0.72 | — | — | |
| SCHEMBL6256822 | 0.72 | — | — | |
| SCHEMBL7955137 | 0.72 | — | — | |
| SCHEMBL4636997 | 0.72 | — | — | |
| SCHEMBL5427936 | 0.72 | — | — | |
| SCHEMBL6571045 | 0.72 | — | — | |
| Bicarbonate SCHEMBL9560498 | 0.69 | MAPT (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4025253-B1 | DRUG ANTIBODY CONJUGATES | PHARMA MAR SA (ES) | 2024-03-20 | — | — | EP | claimed |
| EP-3870234-B1 | ANTIBODY DRUG CONJUGATES COMPRISING ECTEINASCIDIN DERIVATIVES | PHARMA MAR SA (ES) | 2022-12-21 | — | — | EP | claimed |
| EP-4025253-A1 | DRUG ANTIBODY CONJUGATES | Pharma Mar S.A. (ES) | 2022-07-13 | — | — | EP | claimed |
| WO-2021043951-A1 | DRUG ANTIBODY CONJUGATES | PHARMA MAR, S.A. (ES) | 2021-03-11 | — | — | WO | claimed |
| EP-3003386-A1 | ANTIBODY DRUG CONJUGATES | Pharma Mar S.A. (ES) | 2016-04-13 | — | — | EP | claimed |
| WO-2014191578-A1 | ANTIBODY DRUG CONJUGATES | PHARMA MAR, S.A. (ES) | 2014-12-04 | — | — | WO | claimed |
| EP-4025253-B1 | DRUG ANTIBODY CONJUGATES | PHARMA MAR SA (ES) | 2024-03-20 | — | — | EP | disclosed |
| US-20230218774-A1 | DRUG ANTIBODY CONJUGATES | PHARMA MAR, S.A. (ES) | 2023-07-13 | — | — | US | disclosed |
| EP-3870234-B1 | ANTIBODY DRUG CONJUGATES COMPRISING ECTEINASCIDIN DERIVATIVES | PHARMA MAR SA (ES) | 2022-12-21 | — | — | EP | disclosed |
| EP-4025253-A1 | DRUG ANTIBODY CONJUGATES | Pharma Mar S.A. (ES) | 2022-07-13 | — | — | EP | disclosed |
| WO-2021043951-A1 | DRUG ANTIBODY CONJUGATES | PHARMA MAR, S.A. (ES) | 2021-03-11 | — | — | WO | disclosed |
| EP-3003386-A1 | ANTIBODY DRUG CONJUGATES | Pharma Mar S.A. (ES) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014191578-A1 | ANTIBODY DRUG CONJUGATES | PHARMA MAR, S.A. (ES) | 2014-12-04 | — | — | WO | disclosed |
| EP-0474590-A2 | Taurine derivatives, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1992-03-11 | — | — | EP | disclosed |
| EP-0352230-A2 | Optical palmitoylglucopyranoside isomer and process for its preparation | CIBA-GEIGY AG (CH) | 1990-01-24 | — | — | EP | disclosed |